RICHARD D PETERSON

CIK 1430423 · Chief Financial Officer · last filed 2026-06-12

RICHARD D PETERSON is a Chief Financial Officer who has filed 47 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for UVE, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.1M across reported positions. 18 SEC filings were submitted jointly with UNIVERSAL INSURANCE HOLDINGS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.14M

Companies

4

Total Filings

47

Lifetime Open-Market Net

-$2.68M

Filer Profile

Reported Address
1110 WEST COMMERCIAL BOULEVARD
FORT LAUDERDALE, FL 33309
Related Filers
UNIVERSAL INSURANCE HOLDINGS, INC. — 18 joint filings, latest 2026-06-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UVE Director 28,869 $44.33 $1.28M -$52.3K 12 2026-06-12
Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Chief Financial Officer 55,800 $0.01 $759 $0 1 2021-12-14
Sienna Biopharmaceuticals, Inc. (SNNA) Delisted Chief Financial Officer 7,000 $105.0K 2 2017-08-01
MRX EVP, CFO & Corp Treasurer 217,289 $73.00 $15.86M -$2.73M 29 2012-08-17

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 UVE Grant (A) +3,414 $0 EDGAR
2026-03-30 UVE Notice (144) −2,000 -$67.3K EDGAR
2025-12-31 UVE Sell (S) −1,855 -$62.3K EDGAR
2025-12-30 UVE Notice (144) −1,855 -$63.3K EDGAR
2025-07-30 UVE Grant (A) +2,824 $0 EDGAR
2025-06-13 UVE Grant (A) +2,404 $0 EDGAR
2024-06-17 UVE Grant (A) +3,491 $65.0K EDGAR
2023-06-22 UVE Grant (A) +4,005 $0 EDGAR
2022-10-03 UVE Buy (P) +1,075 $10.0K EDGAR
2022-06-14 UVE Grant (A) +5,337 $0 EDGAR
Showing 110 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.